4.6 Article

Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV

期刊

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
卷 28, 期 11, 页码 1175-1183

出版社

OXFORD UNIV PRESS
DOI: 10.1177/2047487319838218

关键词

Cardiovascular risk factors; primary prevention; secondary prevention; population-based; primary care; lifestyle advice

资金

  1. German Ministry of Research and Education within the Comprehensive Heart Failure Centre Wurzburg [BMBF 01EO1004, 01EO1504]
  2. German Ministry of Education and Research (BMBF) within the Comprehensive Heart Failure Centre Wurzburg [BMBF 01EO1004]
  3. European Society of Cardiology, EURObservational Research Programme
  4. AstraZeneca
  5. Bristol-Myers Squibb/Emea Sarl
  6. F. Hoffman-La Roche
  7. Merck, Sharp Dohme
  8. Amgen
  9. GlaxoSmithKline

向作者/读者索取更多资源

The study found that in primary prevention, appropriate PLA was mainly determined by the presence of vascular risk factors, whereas in secondary prevention, the overall level of PLA was higher, but the association between CVD risk factors and PLA was less pronounced.
Background We assessed prevalence and determinants in appropriate physician-led lifestyle advice (PLA) in a population-based sample of individuals without cardiovascular disease (CVD) compared with a sample of CVD patients. Methods PLA was assessed via questionnaire in a subsample of the population-based Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB) cohort free of CVD (primary prevention sample) and the German subset of the fourth EUROASPIRE survey (EUROASPIRE-IV) comprising CVD patients (secondary prevention sample). PLA was fulfilled if the participant reported having ever been told by a physician to: stop smoking (current/former smokers), reduce weight (overweight/obese participants), increase physical activity (physically inactive participants) or keep to a healthy diet (all participants). Factors associated with receiving at least 50% of the PLA were identified using logistic regression. Results Information on PLA was available in 665 STAAB participants (55 +/- 11; 55% females) and in 536 EUROASPIRE-IV patients (67 +/- 9; 18% females). Except for smoking, appropriate PLA was more frequently given in the secondary compared with the primary prevention sample. Determinants associated with appropriate PLA in primary prevention were: diabetes mellitus (odds ratio (OR) 4.54; 95% confidence interval (CI) 1.88-10.95), hyperlipidaemia (OR 3.12; 95% CI 2.06-4.73) and hypertension (OR 1.74; 95% CI 1.15-2.62); in secondary prevention: age (OR per year 0.96; 95% CI 0.93-0.98) and diabetes mellitus (OR 2.33; 95% CI 1.20-4.54). Conclusions In primary prevention, PLA was mainly determined by the presence of vascular risk factors, whereas in secondary prevention the level of PLA was higher in general, but the association between CVD risk factors and PLA was less pronounced.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据